| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $15.09B | +0.2% |
| Cost of Revenue | $11.80B | -0.9% |
| R&D Expense | $57.0M | +16.3% |
| SG&A Expense | $2.65B | +2.4% |
| Interest Expense | $89.0M | -11.0% |
| Pre-tax Income | $414.0M | -4.8% |
| Income Tax | $215.0M | +16.8% |
| Net Income | $198.0M | -21.4% |
| EPS (Basic) | $0.87 |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.62B | +46.9% |
| Accounts Receivable | $1.30B | -3.3% |
| Current Assets | $5.53B | +20.5% |
| Total Assets | $12.55B | +20.1% |
| Current Liabilities | $6.31B | +46.7% |
| Long-term Debt | $3.90B | +34.5% |
| Total Liabilities | $11.26B | +23.4% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $948.0M | +0.6% |
| Investing Cash Flow | -$561.0M | -38.9% |
| Financing Cash Flow | $457.0M | +259.8% |
| -20.2% |
| EPS (Diluted) | $0.85 | -19.0% |
| Stockholders' Equity |
| $1.18B |
| -3.6% |